Biliary Lithotripsy: A Perspective

  1. Johnson L. Thistle, MD; and
  2. Bret T. Petersen, MD
  1. Mayo Medical School
    Rochester, Minnesota

    Excerpt

    The initial reports (1, 2) on gallstone fragmentation using extracorporeal shock-wave lithotripsy have been received with almost unbridled enthusiasm by some physicians and hospital administrators. Others, however, have viewed the data with considerable skepticism and concern. The technology is exciting, but its potential usefulness is difficult to assess. More than a dozen different lithotriptors have been developed, nine of which are currently being tested under research protocols in 80 medical centers in the United States. None of these devices has yet received the approval of the Food and Drug Administration for biliary lithotripsy.

    The Technology All lithotriptors fragment gallstones using

    This 100-word excerpt has been provided in the absence of an abstract.

    Article and Author Information

    • Requests for Reprints: Johnson L. Thistle, MD, Mayo Clinic, Division of Gastroenterology, Rochester, MN 55905.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement